Profile data is unavailable for this security.
About the company
SDS Optic SA is a Poland-based company engaged primarily in medical research. The Company’s primary research activity relates to the oncology sector. The Firm wishes to develop a method for early breast cancer diagnosis. The current method of diagnosis relies on biopsy and histopathology. The purpose of the tests is to identify cancer markers. The Company tries to implement InProbe method, which is faster and more accurate- the method should be able to provide results within 20 minutes. The Company is also engaged in research regarding different kinds of diseases such as fungal diseases. The Company cooperates with specialists from different fields such as biology, medicine, technology, and sciences related to medicine.
- Revenue in PLN (TTM)530.40k
- Net income in PLN-7.39m
- Incorporated2019
- Employees--
- LocationSDS Optic SACentrum ECOTECH-COMPLEXBlock A, ul. Gleboka 39LUBLIN 20-612PolandPOL
- Phone+48 815019463
- Websitehttps://sdsoptic.pl/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cannabis Poland SA | 199.93k | -675.76k | 35.87m | -- | -- | 65.85 | -- | 179.41 | -0.0255 | -0.0255 | 0.0076 | 0.0111 | 0.3018 | 0.8264 | 5.07 | -- | -102.76 | -116.92 | -175.94 | -136.30 | 26.16 | 12.29 | -340.53 | -959.39 | 1.35 | -45.88 | 0.2547 | -- | -47.55 | 50.23 | 14.30 | -- | -- | -- |
| GENOMED SA | 22.48m | 996.34k | 37.00m | -- | 37.13 | 3.65 | 22.91 | 1.65 | 0.7541 | 0.7541 | 17.01 | 7.66 | 2.00 | 6.29 | 13.81 | -- | 8.87 | 7.90 | 10.24 | 9.33 | 42.85 | 38.56 | 4.43 | 3.93 | 4.10 | 3,257.61 | -- | -- | 9.85 | 3.87 | 193.38 | -7.69 | -32.19 | -- |
| Inventionmed SA | 610.00 | -2.46m | 43.40m | 9.00 | -- | 8.10 | -- | 71,141.73 | -0.0121 | -0.0121 | 0.00 | 0.0264 | 0.00002 | -- | 0.0004 | 67.78 | -7.00 | -18.09 | -11.73 | -23.28 | -1,288.53 | -48.77 | -403,196.70 | -43,186.79 | -- | -2.11 | -- | -- | -85.01 | -- | 88.90 | -- | -- | -- |
| BIOGENED SA | 95.56m | 4.20m | 55.02m | 205.00 | 13.09 | -- | 7.12 | 0.5758 | 1.71 | 1.71 | 38.90 | -- | -- | -- | -- | 466,145.20 | -- | 2.92 | -- | 4.13 | 66.42 | 68.04 | 4.40 | 3.31 | -- | 3.68 | -- | -- | 20.02 | 18.88 | 24.33 | 29.89 | 9.88 | -- |
| Read Gene SA | 10.05m | -1.85m | 58.83m | 11.00 | -- | 13.34 | -- | 5.85 | -0.1954 | -0.1954 | 1.06 | 0.3741 | 0.666 | 48.81 | 4.51 | -- | -12.24 | -1.71 | -13.14 | -2.11 | 88.57 | 88.01 | -18.37 | -3.90 | 6.46 | -4.19 | -- | -- | 38.79 | 15.77 | -966.00 | -- | -- | -- |
| Medicofarma Biotech SA | 750.81k | -2.67m | 59.01m | -- | -- | 5.93 | -- | 78.59 | -0.0393 | -0.0393 | 0.011 | 0.1463 | 0.0468 | 3.57 | 1.51 | -- | -16.65 | -13.16 | -21.54 | -15.86 | 65.45 | 29.92 | -355.88 | -37.81 | 0.6358 | -14.54 | -- | -- | -82.34 | -31.48 | -68.11 | -- | -- | -- |
| BioMaxima SA | 49.06m | 807.00k | 59.12m | -- | 79.64 | 1.16 | 19.11 | 1.21 | 0.1771 | 0.1771 | 11.37 | 12.14 | 0.6711 | 2.03 | 5.48 | -- | 1.10 | 18.57 | 1.28 | 27.40 | 44.59 | 40.02 | 1.64 | 13.16 | 0.8498 | 7.50 | 0.152 | -- | 79.46 | 35.74 | 182.00 | 104.60 | 35.44 | -- |
| Onesano SA | 13.09m | -5.21m | 83.01m | 51.00 | -- | 4.83 | -- | 6.34 | -0.0812 | -0.0812 | 0.2083 | 0.2611 | 0.5449 | 1.98 | 6.21 | 272,645.80 | -21.70 | -35.13 | -25.97 | -- | 43.38 | 52.79 | -39.83 | -32.03 | 3.40 | -- | 0.0296 | -- | 5.80 | 30.63 | -225.52 | -- | 14.67 | -- |
| Urteste SA | 0.00 | -5.59m | 132.51m | -- | -- | 4.78 | -- | -- | -4.52 | -4.52 | 0.00 | 19.68 | 0.00 | 3.86 | -- | -- | -30.78 | -- | -32.71 | -- | -- | -- | -- | -- | 17.11 | -- | 0.0221 | -- | -100.00 | -- | -37.59 | -- | -- | -- |
| Sds Optic SA | 530.40k | -7.39m | 134.01m | -- | -- | 19.11 | -- | 252.65 | -1.30 | -1.30 | 0.0928 | 1.19 | 0.054 | -5.91 | 2.11 | -- | -75.38 | -- | -94.39 | -- | 167.64 | -- | -1,395.87 | -- | 4.85 | -- | 0.00 | -- | -99.59 | -- | -85.26 | -- | -- | -- |
| Genomtec SA | 1.00k | -9.01m | 154.45m | -- | -- | 18.60 | -- | 154,449.40 | -0.8037 | -0.8037 | 0.00009 | 0.6773 | 0.00007 | 15.45 | 0.0008 | -- | -65.01 | -- | -80.98 | -- | -81,000.00 | -- | -901,300.00 | -- | 2.11 | -46.67 | 0.1613 | -- | -97.50 | -- | 24.44 | -- | -- | -- |
| Poltreg SA | 1.40m | -13.55m | 219.65m | 23.00 | -- | 2.51 | -- | 157.00 | -2.91 | -2.91 | 0.300 | 18.77 | 0.0112 | 51.22 | 27.43 | 61,494.50 | -10.82 | -6.51 | -12.42 | -7.35 | -811.65 | -391.38 | -968.62 | -449.24 | 3.87 | -- | 0.0856 | -- | 40.04 | -- | -588.92 | -- | 214.26 | -- |
| Molecure SA | 1.31m | -18.31m | 246.48m | 111.00 | -- | 1.57 | -- | 188.36 | -1.17 | -1.17 | 0.0847 | 9.34 | 0.0085 | -- | 0.2818 | 11,788.92 | -11.94 | 2.52 | -12.47 | 2.64 | -25.76 | 97.54 | -1,398.86 | 12.84 | -- | -- | 0.0434 | -- | -18.85 | 237.24 | -19.67 | -- | -24.82 | -- |
Data as of May 17 2024. Currency figures normalised to SDS Optic SA's reporting currency: Polish New Zloty PLN
2.67%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2023 | 157.00k | 2.67% |
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
